REFERENCES
- Roger VL, Go AS, Lloyd-Jones DM, . Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 2011; 123:e18–e209.
- Bonita R. Epidemiology of stroke. Lancet 1992; 339:342–344.
- Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007; 6:149–161.
- O’Donnell MJ, Xavier D, Liu L, . Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376:112–123.
- Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol 2007; 22:176–184.
- Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35:212–227.
- Lang RE, Unger T, Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens 1987; 5:255–271.
- Nicholls MG, Espiner EA, Ikram H, Crozier IG, Richards AM. Atrial natriuretic peptide in human hypertension. Eur Heart J 1987; 8 (Suppl. B):123–128.
- Jernberg T, James S, Lindahl B, . Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004; 25:1486–1493.
- Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 2007; 53:813–822.
- Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005; 330:625.
- Maack T, Nikonova LN, Friedman O, Cohen D. Functional properties and dynamics of natriuretic peptide receptors. Proc Soc Exp Biol Med 1996; 213:109–116.
- Nakayama T. The genetic contribution of the natriuretic peptide system to cardiovascular diseases. Endocr J 2005; 52:11–21.
- Ikram MA, Seshadri S, Bis JC, . Genomewide association studies of stroke. N Engl J Med 2009; 360:1718–1728.
- Pitzalis MV, Sarzani R, Dessi-Fulgheri P, . Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003; 21:1491–1496.
- Sarzani R, Dessi-Fulgheri P, Salvi F, . A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999; 17:1301–1305.
- Aoi N, Soma M, Nakayama T, . Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004; 27:711–716.
- Johnson GC, Esposito L, Barratt BJ, . Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29:233–237.
- Purcell S, Neale B, Todd-Brown K, . PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559–575.
- Lee JK, Kim HT, Cho SM, . Characterization of 458 single nucleotide polymorphisms of disease candidate genes in the Korean population. J Hum Genet 2003; 48:213–216.
- Rahmutula D, Nakayama T, Soma M, . Structure and polymorphisms of the human natriuretic peptide receptor C gene. Endocrine 2002; 17:85–90.
- Saulnier PJ, Roussel R, Halimi JM, . Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes. Diabetes Care 2011; 34:1199–1204.
- Iemitsu M, Maeda S, Otsuki T, . Arterial stiffness, physical activity, and atrial natriuretic Peptide gene polymorphism in older subjects. Hypertens Res 2008; 31:767–774.
- Kato N, Takeuchi F, Tabara Y, . Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 2011; 43:531–538.
- Rubattu S, Sciarretta S, Morriello A, Calvieri C, Battistoni A, Volpe M. NPR-C: a component of the natriuretic peptide family with implications in human diseases. J Mol Med (Berl) 2010; 88:889–897.